Facebook-f Twitter Linkedin Youtube
SUBSCRIBE
Facebook-f Twitter Linkedin Youtube

RMEI Educational Outcomes

View Details

Current and Emerging Anti-VEGF Therapy Dosing Regimens for nAMD and DME

Iqbal was only 32 years old when he had his first, and rather sudden, experience with diabetic eye disease. While at work, he experienced a sudden flash of light that left what he described as a fingerprint in the middle of his vision in one eye. Although it got better by the day, it limited everything he could do, from reading to driving.
Presentation Year: 2023
View Details

An Inflammatory Bowel Disease (IBD) Decision Support Tool Predicts Drug Specific Remission and Improves Provider Mastery in Treatment Selection

The CDST is unique among point-of-care tools in that it provides differential predictions for endoscopic remission with vedolizumab, adalimumab, and tofacitinib. This tool, which has the potential to improve patient outcomes, was supported and disseminated via web-based education. Findings from data collected during the 3 successive years of programming to-date revealed a significant increase in clinical mastery. Ultimately, clinicians engaged with this patient population who have participated in the education are more likely to use the tool regularly and correctly, as well as disseminating it amongst their colleagues.​
Presentation Year: 2023
Presented at: Digestive Disease Week (DDW)
View Details

Multi-Year Education Facilitated the Clinical Implementation of a Novel Point-of-Care Tool

The third installment of the US IBD Health Outcomes Consortium (HOC) initiative built upon insights gained from Phases I & II and was designed to empower gastroenterology clinicians to utilize the Clinical Decision Support Tool (CDST, a Web-based, interactive point-of-care tool accessible from any device, which provides guidance on optimal treatment selection based on prognostic and predictive modeling), in clinical practice. While Phases I & II focused on explanation of what the tool is and how to use it, Phase III the central goal was to enable clinicians to leverage that learning to use this novel tool in their clinical practice. Following their participation in the most recent education, 100% of gastroenterologists reported intent to use the tool (82% of whom reported they would not use the tool at Pre-Test).
Presentation Year: 2023
Presented at: American Board of Medical Specialties (ABMS)
View Details

How Education Facilitated Uptake of a Novel Point of Care Decision Aid in IBD: The IBD Clinical Decision Support Tool

ACG 2023 Poster: There has been a progressive increase in the frequency of CDST usage between October 2019 and August 2023. 30,172 patient scenarios have been input into the IBD CDST to date. ​Serial education facilitated the real time observation of increases in clinician empowerment via course content adapted to meet demonstrated need.​ In real terms, learners pivoted their demonstrated mastery (243% overall improvement in correctness and confidence in their correctness) into substantially increased usage of the tool and by extension improved clinical efficacy. As of the last survey clinicians demonstrable appreciation of the value of the tool is their organic peer to peer dissemination of the IBD CDST.
Presentation Year: 2023
Presented at: American Gastroenterology Association (AGA)
View Details

Don’t Treat Your Patients with Prurigo Nodularis the Way this Dermatologist Did

Two years ago, TLC aired an episode about a young Black woman named Natalie who broke out in tears while describing a condition that mysteriously appeared all over her skin. She showed her arms and legs to the camera, displaying a series of evenly spaced, raised, pigmented nodules, and described an intense need to scratch them.
Presentation Year: 2023
View Details

The Oncology Nursing Mistake That is Hurting Your Practice

Non-melanoma skin cancers (NMSC) are common. Fortunately, they tend to have excellent survival and cure rates, but some of the more locally advanced and metastatic forms do not.
Presentation Year: 2023
View Details

What a Perfect NCFBE Patient Looks Like… And Why It’s a Problem

Woody was diagnosed with bronchiectasis in 1996 after the death of his wife. He struggled with fevers, infections, and just trying to get around. Although looking at him now at 80 years old, it is kind of hard to imagine that used to be the case.
Presentation Year: 2023
View Details

Intravitreal Anti-VEGF & Bispecific Therapies for DME & nAMD

In late 2022, the ocular implant, insertion tool assembly, (including the drug vial & initial fill needle) for ranibizumab PDS were voluntarily recalled due to septum dislodgement and paused implantations including ongoing global clinical trials; this did not include the refill vial and needle.
Presentation Year: 2023
View Details

Cervical Cancer: What You Need to Know About Screening, Symptoms, and Treatments

This Decision Support Aid serves as a quick reference to help clinicians to apply information to their daily practice and care of patients. An estimated 13,960 women are diagnosed with invasive cervical cancer every year.
Presentation Year: 2023
View Details

Navigating Nontuberculous Mycobacteria Lung Disease

This Decision Support Aid serves as a quick reference to help clinicians to apply information to their daily practice and care of patients. Nontuberculous mycobacterial lung disease (NTM-LD) is challenging and often delayed due to non-specific symptoms, indolent disease course, and similarities to tuberculosis and other lung diseases; several barriers to its treatment also persist.
Presentation Year: 2023

Copyright © 2024. RMEI Medical Education, LLC. All rights reserved​

Privacy | Terms of Use